跳至主要内容
临床试验/ITMCTR2100004379
ITMCTR2100004379招募中未知

A Randomized Controlled Trial for Qing Jin Yi Qi granule in the treatment of Convalescence Patients of Novel Coronavirus Pneumonia(COVID-19)

Shijiazhuang People's Hospital0 个研究点开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1) Conform to the diagnostic criteria of COVID-19(Guidelines for the diagnosis and treatment of coronavirus disease 2020(trial version eighth))Patients who met the discharge standard and had negative neocoronavirus nucleic acid detection after discharge
  • 2) Aged 18-75 years;
  • 3) Having clinical manifestations of respiratory symptoms or fatigue;
  • 4) Patient informed consent.

排除标准

  • 1) Patients who have undergone operations that affect lung function, such as lung transplantation, lung resection, lung volume reduction, etc;
  • 2) Dependent on mechanical ventilation to maintain lung function, such as ventilator;
  • 3) Combined with chronic lung diseases that affect lung function, such as severe chronic obstructive pulmonary disease;
  • 4) Patients with heart function related diseases, such as heart failure and pacemaker installation;
  • 5) Severe underlying diseases affecting survival, including uncontrolled heart, kidney, digestive, blood diseases, neuropsychiatric diseases, immune diseases, metabolic diseases, malignant tumors, severe malnutrition, etc;
  • 6) Resting heart rate > 120 / min;
  • 7) Systolic blood pressure > 180mmhg, diastolic blood pressure > 100mmhg;
  • 8) Unstable angina pectoris or myocardial infarction in recent 1 month;
  • 9) Severe obesity (BMI > 30 kg / m2);
  • 10) Allergic constitution, allergic to the drug components involved in the treatment program;
  • 11) Pregnant or lactating women;
  • 12) Disabled people who can't complete the collection of efficacy evaluation indicators;
  • 13) Mental state can not cooperate, suffering from mental illness, no self-control, can not express clearly;
  • 14) Participants in other clinical trials;
  • 15) According to the judgment of the researchers, there will be patients with complications or poor compliance that affect the efficacy and safety evaluation.

研究者

发起方
Shijiazhuang People's Hospital

相似试验

尚未招募
不适用
A randomized controlled trial for 'Xing-Nao Kai-Qiao' Rehabilitation Program in the Treatment of Motor Aphasia after StrokeAphasia after Stroke
ITMCTR1900002688The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
尚未招募
1 期
A random, multi-center controlled trial for Qi-Jing Hui-Xin Decoction in the treatment of microvascular anginamicrovascular angina
ITMCTR1900002719Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
招募中
1 期
A randomized controlled trial for Yi-Sheng Xiao-Zheng granules in the treatment of dysmenorrhea caused by pelvic endometriosis (syndrome of kidney deficiency and blood stasis)Endometriosis
ITMCTR1900002773Dongfang Hospital of Beijing University of Chinese Medicine
已完成
2 期
Clinical trial of a Chinese herbal medicine for the treatment of prediabetes and mild diabetesImpaired glucose tolerance defined as having a fasting blood glucose <7.8 mmol and a 2 hour post prandial blood glucose >7.8 but <11.00Mild diabetes defined as those with diabetes diagnosed within 5 yrs of enrolment in the clinical trial, diet and exercise controlled and not taking any medications.Metabolic and Endocrine - DiabetesAlternative and Complementary Medicine - Herbal remedies
ACTRN12612000128897Xiyuan Hospital100
尚未招募
2 期
A randomized controlled clinical Trial for Qingre Huayu Formula on left ventricular remodeling in patients with ST segment elevation myocardial infarctioST segment elevation myocardial infarction
ITMCTR2000003834Shuguang Hospital of Shanghai University of Traditional Chinese